TP53 and acute myeloid leukemia: An even higher frequency of mutant TP53 is associated with the complex karyotype subtype of AML, in which the frequency of TP53 mutations reaches up to 70%, mainly due to selective pressure caused by acquired resistance to DNA damage following chemotherapy and radiotherapy.